Ziv-Aflibercept as a possible alternative to aflibercept: Will the story of aflibercept and ziv-aflibercept be a case of déjà vu that recalls the case of ranibizumab and bevacizumab?

Jonathan S. Chang, Thomas A. Albini, Andrew A. Moshfeghi

Research output: Contribution to journalComment/debatepeer-review

3 Scopus citations
Original languageEnglish (US)
Pages (from-to)67-68
Number of pages2
JournalRetina Today
StatePublished - Jan 1 2014

ASJC Scopus subject areas

  • Ophthalmology

Cite this